GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Net Income (Continuing Operations)

Ibex Technologies (TSXV:IBT) Net Income (Continuing Operations) : C$3.98 Mil (TTM As of Jan. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ibex Technologies's Net Income (Continuing Operations) for the three months ended in Jan. 2024 was C$0.05 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2024 was C$3.98 Mil.


Ibex Technologies Net Income (Continuing Operations) Historical Data

The historical data trend for Ibex Technologies's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Net Income (Continuing Operations) Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.27 0.97 0.76 1.67 3.89

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.89 2.22 0.81 0.05

Ibex Technologies Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3.98 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ibex Technologies  (TSXV:IBT) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.


Ibex Technologies Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Industry
Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines